1. Home
  2. ICUI vs AQN Comparison

ICUI vs AQN Comparison

Compare ICUI & AQN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ICUI
  • AQN
  • Stock Information
  • Founded
  • ICUI 1984
  • AQN 1988
  • Country
  • ICUI United States
  • AQN Canada
  • Employees
  • ICUI N/A
  • AQN N/A
  • Industry
  • ICUI Medical/Dental Instruments
  • AQN Electric Utilities: Central
  • Sector
  • ICUI Health Care
  • AQN Utilities
  • Exchange
  • ICUI Nasdaq
  • AQN Nasdaq
  • Market Cap
  • ICUI 3.8B
  • AQN 3.4B
  • IPO Year
  • ICUI 1992
  • AQN 1998
  • Fundamental
  • Price
  • ICUI $160.82
  • AQN $4.54
  • Analyst Decision
  • ICUI Buy
  • AQN Hold
  • Analyst Count
  • ICUI 4
  • AQN 7
  • Target Price
  • ICUI $199.67
  • AQN $5.96
  • AVG Volume (30 Days)
  • ICUI 206.7K
  • AQN 8.5M
  • Earning Date
  • ICUI 02-25-2025
  • AQN 03-07-2025
  • Dividend Yield
  • ICUI N/A
  • AQN 5.73%
  • EPS Growth
  • ICUI N/A
  • AQN N/A
  • EPS
  • ICUI N/A
  • AQN N/A
  • Revenue
  • ICUI $2,340,097,000.00
  • AQN $2,614,452,000.00
  • Revenue This Year
  • ICUI $4.38
  • AQN N/A
  • Revenue Next Year
  • ICUI $0.34
  • AQN N/A
  • P/E Ratio
  • ICUI N/A
  • AQN N/A
  • Revenue Growth
  • ICUI 4.04
  • AQN 1.88
  • 52 Week Low
  • ICUI $87.65
  • AQN $4.19
  • 52 Week High
  • ICUI $196.26
  • AQN $6.79
  • Technical
  • Relative Strength Index (RSI)
  • ICUI 45.43
  • AQN 52.14
  • Support Level
  • ICUI $155.00
  • AQN $4.26
  • Resistance Level
  • ICUI $173.85
  • AQN $4.57
  • Average True Range (ATR)
  • ICUI 5.70
  • AQN 0.16
  • MACD
  • ICUI -0.86
  • AQN 0.02
  • Stochastic Oscillator
  • ICUI 28.35
  • AQN 67.59

About ICUI ICU Medical Inc.

ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (43% of consolidated revenue), infusion systems (28%), and vital care (29%). The combined entity remains primarily US-focused, generating over 63% of its sales domestically.

About AQN Algonquin Power & Utilities Corp.

Algonquin Power & Utilities Corp, a parent company of Liberty, is a diversified international generation, transmission, and distribution utility with over $16 billion of total assets. Through its two business groups, the Regulated Services Group and the Renewable Energy Group, AQN is committed to providing safe, secure, reliable, cost-effective, and sustainable energy and water solutions through its portfolio of electric generation, transmission, and distribution utility investments to over one million customer connections, largely in the United States and Canada. AQN provides renewable energy through its portfolio of long-term contracted wind, solar, and hydroelectric generating facilities.

Share on Social Networks: